Air Canada (TSX:AC) Could Soar to $33 by Summer

Air Canada (TSX:AC) could skyrocket into the summer travel season, but are the COVID-19 variant risks too high amid this latest wave?

| More on:

Air Canada (TSX:AC) stock has been a turbulent ride, to say the least. Canadians have been punching their ticket to the red-hot airline play that recently got a boost courtesy of the federal government, which now has an equity stake. With a deep-pocketed saviour in Ottawa standing in its corner, I think Air Canada stock will live to see better days. It’s just a matter of when the horrific coronavirus will abate in the ongoing war between vaccines and variants.

Right now, variants have the upper hand, with many provinces grappling with lockdown to slow the spread. Every day that goes by, though, more jabs of vaccines are put in arms. And as the summertime travel season rolls around, I think we’ll be the closest to normalcy we’ve been for the duration of this pandemic. There’s a tonne of pent-up air travel demand, and it will be met in due time. That said, I have no idea if Air Canada will miss peak travel season this summer, as it did last year.

All eyes on the vaccine rollout

The vaccine rollout has been relatively slow in Canada. The government ordered new boosters from Pfizer, and there should be a steady supply incoming over the next few years. As the federal government looks to accelerate vaccination efforts, I think Air Canada could see some pressure alleviated with its domestic-focused flights. This combined with readily available financial support from the federal government, I believe, essentially guarantees Air Canada’s survival, as we enter the latter stages of this horrific pandemic.

However, I believe Air Canada’s recovery will be dependent on the worldwide vaccine effort. Air Canada is an international airline at heart. Until the COVID-19 crisis abates at the international level, I think it will be hard for Air Canada to reach 2019 levels of traffic.

Undoubtedly, international airlines face a tough uphill climb en route to normalcy, whereas domestic airlines will have it easier.

Plenty of analysts out there, including my fellow Fool contributor Chris MacDonald, are bullish on Air Canada stock. They view the crisis as temporary and a recovery as inevitable, given the federal government’s backing. Sure, Air Canada is bleeding cash, but its balance sheet is less of an issue given Ottawa’s willingness to lend a helping hand when needed.

Air Canada: The perfect reopening play for the cautious bull

“For bulls who believe the recovery coming out of this pandemic will be strong, Air Canada is still a great recovery pick. I’d recommend easing into such a position today for those interested in picking up Air Canada as a long-term holding.” wrote MacDonald.

I think Mr. MacDonald is right on the money in that Canadians looking to get in should do so gradually over time, given the turbulence in the name and uncertainties relating to coronavirus variants. As of right now, vaccines should help protect against most variants rather well. Of course, there’s always a chance that one variant of interest could prove to be more virulent and infectious, rendering today’s slate of vaccines far less effective. However, the discovery of such an elusive and insidious variant, I think, is a high-impact but low-probability event.

If you’ve got a stomach for turbulence and are bullish on vaccines, I think there’s a got to gain from the stock as we move towards normalcy. The Street’s high target for Air Canada stock is $33, implying 32% upside from today’s levels. Personally, I’m waiting for a pullback to $20 before considering initiating a position and would encourage you to wait for such a level, unless you’re keen on the name.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of Pfizer.

More on Coronavirus

A airplane sits on a runway.
Coronavirus

3 Fresh Stocks I’m Likely Buying in 2025

I am likely buying Air Canada (TSX:AC) stock in 2025.

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Coronavirus

Canadian RRSP Stocks to Buy Now for Retirement

Alimentation Couche-Tard Inc (TSX:ATD) is a quality retirement stock.

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Coronavirus

Retirees: What Rising Inflation Means for Your CPP Payments

If you aren't getting enough CPP, you can consider investing in stocks and ETFs. Canadian National Railway (TSX:CNR) is one…

Read more »

Coronavirus

Air Canada Stock Is Starting to Get Ridiculously Oversold

Air Canada (TSX:AC) has been beaten down to absurd lows.

Read more »

Coronavirus

Should You Buy Air Canada Stock While it’s Below $18?

Air Canada (TSX:AC) stock is below $18. Should you invest?

Read more »

Illustration of data, cloud computing and microchips
Stocks for Beginners

3 Canadian Stocks That Could Still Double in 2024

These three Canadians stocks have been huge winners already in 2024, but still have room to double again in the…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Can Air Canada Stock Recover in 2024?

Air Canada (TSX:AC) stock remains close to its COVID-19 era lows, even though its business has recovered.

Read more »

A airplane sits on a runway.
Coronavirus

3 Things to Know About Air Canada Stock Before You Buy

Air Canada stock continues to hover below $20 despite the sharp rise in travel demand seen across the industry. What's…

Read more »